Researchers discover how Hepatitis C virus persists for years

A cultured liver cancer cell infected with Hepatitis C. The virus, stained red, surrounds the blue-stained nucleus and is in the process of being reproduced by virus within the cytoplasm. Credit: Takahiro Masaki/UNC Lemon Lab

Hepatitis C virus (HCV) lingers in the human body for years, slowly damaging the liver and leading to liver diseases such as hepatitis, cirrhosis and liver cancer, which is often fatal. Research conducted at the University of North Carolina at Chapel Hill has discovered a mechanism that facilitates the virus achieving this life-long persistence. Chronic HCV infection is the leading cause of liver cancer in the United States.

"Liver cancer is one of the most important causes of cancer mortality worldwide. It's also increasing in rapidly incidence within the United States, due largely to the spread of HCV among Americans in the 60s and 70s," said Stanley M. Lemon, MD, Professor of Medicine at the UNC School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center.

In a paper published online by Nature Medicine this week, a team led by Dr. Lemon and colleague Daisuke Yamane, DVM, PhD, found that HCV has a sensor function that allows it to be regulated by the oxidative damage to cell membranes that occurs as a byproduct of its replication and the body's response to it. This slows down virus growth when oxidative membrane damage becomes too high, but allows it to resume when the membrane damage is reduced. By auto-regulating its replication in this way, the virus maintains a low profile, helping it escape detection by the immune system. 

"You might consider it like a thermostat," said Dr. Lemon, "one that regulates the growth of the virus like your thermostat regulates the temperature of your house."

The reason why HCV is able to achieve life-long persistence in most individuals who become infected has never been well explained. "What we have done in this paper is to show that the replication of a wide variety of hepatitis C virus strains is uniquely regulated by in the liver. This is an absolutely unique attribute of that sets it apart from similar viruses," said Dr. Lemon.

Oxidative stress occurs when tissue injury generates free radicals, normal biological byproducts that can cause cellular damage when present in excess amounts. This promotes to inflammation and progressive scarring within the liver, leading to further disease like cirrhosis and cancer. Lipid peroxidation occurs on membranes when there are excess free radicals, and that regulates the growth of hepatitis C virus. By reducing its replication, the virus is able to persist at low levels in the liver for years. This slows the damage to the host and helps the virus to escape the attention of the body's immune system.

This autoregulatory circuit has made HCV very difficult to study in the laboratory. The virus does not grow well in cell cultures because of oxidative stress. Dr. Lemon's team have identified mutants of the virus which have lost the ability to be regulated by , and these grow much more efficiently in the laboratory.

"That allows us to use those viruses to test anti-viral drugs and possibly also for vaccine development," said Dr. Lemon.

More information: "Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation." Daisuke Yamane, et al. Nature Medicine (2014) DOI: 10.1038/nm.3610. Received 31 March 2014 Accepted 23 May 2014 Published online 27 July 2014

add to favorites email to friend print save as pdf

Related Stories

Predicting the outcome of hepatitis C virus treatment

Jul 01, 2014

Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully ...

Hepatitis C virus genotype 1 is most prevalent worldwide

Jul 28, 2014

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

New focus to combat rising liver disease

Jul 26, 2013

University of Adelaide researchers are investigating how the liver responds to hepatitis C virus (HCV) and why some people can control the virus while others can't. The aim is to find better therapies to combat hepatitis ...

Recommended for you

Evidence-based recs issued for systemic care in psoriasis

12 hours ago

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

12 hours ago

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

13 hours ago

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

Discovery of genes that predispose a severe form of COPD

15 hours ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

On the environmental trail of food pathogens

16 hours ago

Tracking one of the deadliest food contamination organisms through produce farms and natural environments alike, Cornell microbiologists are showing how to use big datasets to predict where the next outbreak could start.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Nik_2213
not rated yet Jul 29, 2014
This is why we need an HPC vaccine to complement the HPV vaccine, and enough uptake to crowd these little horrors out of the community.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.